menu
    • menu

    Company profile for Vaxxinity

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer'...
    Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VaxxinityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1717 Main St, Suite 3388 Dallas, TX 75201
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vaxxinity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vaxxinity/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/vaxxinity

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine
    Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine

    20 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/20/2901487/0/en/Vaxxinity-UB-312-Parkinson-s-Trial-Results-Published-in-Nature-Medicine.html

    GLOBENEWSWIRE
    20 Jun 2024
    Share Share
    Vaxxinity retreats from 'abusive relationship' of public market
    Vaxxinity retreats from 'abusive relationship' of public market

    15 May 2024

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vaxxinity-retreats-abusive-relationship-after-3-years-public-markets

    Annalee Armstrong FIERCE BIOTECH
    15 May 2024
    Share Share
    Vaxxinity Issues Shareholder Letter
    Vaxxinity Issues Shareholder Letter

    19 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/19/2866409/0/en/Vaxxinity-Issues-Shareholder-Letter.html

    GLOBENEWSWIRE
    19 Apr 2024
    Share Share
    Vaxxinity To Voluntarily Delist, Deregister Class A Common Stock
    Vaxxinity To Voluntarily Delist, Deregister Class A Common Stock

    19 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/19/2866373/0/en/Vaxxinity-Announces-Intention-to-Voluntarily-Delist-and-Deregister-its-Class-A-Common-Stock.html

    GLOBENEWSWIRE
    19 Apr 2024
    Share Share
    Vaxxinity to Present Clinical Data at the Annual Academy of Neurology Meeting
    Vaxxinity to Present Clinical Data at the Annual Academy of Neurology Meeting

    28 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/28/2854092/0/en/Vaxxinity-to-Present-Clinical-Data-at-the-Annual-Academy-of-Neurology-2024-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results
    Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results

    27 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/27/2853637/0/en/Vaxxinity-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search